Award
National Cancer Institute 5R01CA261937-05
Functional and Therapeutic Significance of PLK4 in Melanoma
Recipient
Not specified
Award Amount
$547,582.00
Ceiling
$547,582.00
Awarded
June 24, 2026
Identifier
5R01CA261937-05
NIH-funded research project awarded by the National Cancer Institute to study the role and therapeutic potential of PLK4 in melanoma.
Description
This is a NIH-funded research project focusing on the role of PLK4 in melanoma, with objectives including ex vivo and in vivo studies, and potential therapeutic implications.